AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

United States Specialty Generics Market Outlook 2019-2024: $32.6 Billion Opportunity Analysis - ResearchAndMarkets.com

May 7, 2019

DUBLIN--(BUSINESS WIRE)--May 7, 2019--The “United States Specialty Generics Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024” report has been added to ResearchAndMarkets.com’s offering.

The United States Specialty Generics Market reached a value of US$ 18.4 Billion in 2018. Looking forward, the market is projected to reach US$ 32.6 Billion by 2024, exhibiting a CAGR of around 10% during 2019-2024.

Specialty generics are economical compared to specialty drugs as they don’t need to undergo the costly and time-consuming research and development procedures required for their branded versions. Moreover, marketing and promotional expenses for speciality generics are also lower compared to their branded versions. This results in significant savings for patients, government and healthcare providers.

Moreover, the market is also being catalysed by a rising ageing population in the United States. This has resulted in an increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, hepatitis, HIV, autoimmune disease, etc. For instance, as per the American cancer society, a total of 1,762,450 new cancer cases and 606,880 deaths from cancer are expected to occur in the United States in 2019.

Additionally, the patent expiration of several blockbuster branded specialty drugs is further expected to catalyse the market growth in the coming years.

Key Questions Answered

  • How has the US specialty generics market performed so far and how will it perform in the coming years?
  • What is the breakup of the US specialty generics market based on the route of administration?
  • What is the breakup of the US specialty generics market based on the indication?
  • What is the breakup of the US specialty generics market based on the distribution channel?
  • What are the various stages in the value chain of the US specialty generics industry?
  • What are the key driving factors and challenges in the US specialty generics market?
  • What is the structure of the US specialty generics industry and who are the key players?
  • What is the degree of competition in the US specialty generics market?

Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Global Specialty Generics Market: Introduction

4.1 What are Specialty Generic Drugs?

4.2 Types of Specialty Generics

5 Why are Specialty Generics So Lucrative?

6 Global Specialty Generics Market

6.1 Market Overview

6.2 Market Performance

6.3 Market Breakup by Route of Administration

6.4 Market Breakup by Indication

6.5 Market Breakup by Distribution Channel

6.6 Market Breakup by Region

6.7 Market Forecast

7 US Specialty Generics Market

7.1 Market Overview

7.2 Market Performance

7.3 Market Breakup by Route of Administration

7.4 Market Breakup by Indication

7.5 Market Breakup by Distribution Channel

7.6 Market Forecast

7.7 SWOT Analysis

7.8 Value Chain Analysis

7.9 Porters Five Forces Analysis

7.10 Key Market Drivers and Success Factors

8 Market Breakup by Route of Administration

8.1 Injectables

8.2 Oral

8.3 Others

9 Market Breakup by Indication

9.1 Oncology

9.2 Autoimmune Diseases

9.3 Infectious Diseases

9.4 Others

10 Market Breakup by Distribution Channel

10.1 Retail Pharmacies

10.2 Specialty Pharmacies

10.3 Hospital Pharmacies

11 Competitive Landscape

11.1 Market Structure

11.2 Key Players

11.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/ekqs4d

View source version on businesswire.com:https://www.businesswire.com/news/home/20190507005891/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Generic Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/07/2019 12:55 PM/DISC: 05/07/2019 12:55 PM

http://www.businesswire.com/news/home/20190507005891/en